Literature DB >> 23843589

The HONEYPOT randomized controlled trial statistical analysis plan.

Elaine Mary Pascoe1, Serigne Lo, Anish Scaria, Sunil V Badve, Elaine Mary Beller, Alan Cass, Carmel Mary Hawley, David W Johnson.   

Abstract

BACKGROUND: The HONEYPOT study is a multicenter, open-label, blinded-outcome, randomized controlled trial designed to determine whether, compared with standard topical application of mupirocin for nasal staphylococcal carriage, exit-site application of antibacterial honey reduces the rate of catheter-associated infections in peritoneal dialysis patients.
OBJECTIVE: To make public the pre-specified statistical analysis principles to be adhered to and the procedures to be performed by statisticians who will analyze the data for the HONEYPOT trial.
METHODS: Statisticians and clinical investigators who were blinded to treatment allocation and treatment-related study results and who will remain blinded until the central database is locked for final data extraction and analysis determined the statistical methods and procedures to be used for analysis and wrote the statistical analysis plan. The plan describes basic analysis principles, methods for dealing with a range of commonly encountered data analysis issues, and the specific statistical procedures for analyzing the primary, secondary, and safety outcomes.
RESULTS: A statistical analysis plan containing the pre-specified principles, methods, and procedures to be adhered to in the analysis of the data from the HONEYPOT trial was developed in accordance with international guidelines. The structure and content of the plan provide sufficient detail to meet the guidelines on statistical principles for clinical trials produced by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.
CONCLUSIONS: Making public the pre-specified statistical analysis plan for the HONEYPOT trial minimizes the potential for bias in the analysis of trial data and the interpretation and reporting of trial results.

Entities:  

Keywords:  International Conference on Harmonization; Randomized controlled trial; catheter-associated infections; intention-to-treat; outcome reporting bias; pre-specified statistical analyses; statistical analysis plan

Mesh:

Year:  2013        PMID: 23843589      PMCID: PMC3707722          DOI: 10.3747/pdi.2012.00310

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  27 in total

1.  ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group.

Authors: 
Journal:  Stat Med       Date:  1999-08-15       Impact factor: 2.373

2.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

3.  Efficient evaluation of treatment effects in the presence of missing covariate values.

Authors:  M Schemper; T L Smith
Journal:  Stat Med       Date:  1990-07       Impact factor: 2.373

4.  Sample size slippages in randomised trials: exclusions and the lost and wayward.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

5.  Exit-site healing post catheter implantation.

Authors:  Z J Twardowski; B F Prowant
Journal:  Perit Dial Int       Date:  1996       Impact factor: 1.756

6.  Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies.

Authors:  T A Golper; M E Brier; M Bunke; M J Schreiber; D K Bartlett; R W Hamilton; F Strife; R J Hamburger
Journal:  Am J Kidney Dis       Date:  1996-09       Impact factor: 8.860

7.  Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations.

Authors:  Stephen P McDonald; John F Collins; Markus Rumpsfeld; David W Johnson
Journal:  Perit Dial Int       Date:  2004 Jul-Aug       Impact factor: 1.756

8.  Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients.

Authors:  C M Sewell; J Clarridge; C Lacke; E J Weinman; E J Young
Journal:  JAMA       Date:  1982-09-24       Impact factor: 56.272

9.  Frequency and microbiology of peritonitis and exit-site infection among obese peritoneal dialysis patients.

Authors:  Sharon J Nessim; Paul Komenda; Claudio Rigatto; Mauro Verrelli; Manish M Sood
Journal:  Perit Dial Int       Date:  2012-09-01       Impact factor: 1.756

10.  Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD).

Authors:  S J Davies; C S Ogg; J S Cameron; S Poston; W C Noble
Journal:  Perit Dial Int       Date:  1989       Impact factor: 1.756

View more
  5 in total

Review 1.  Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.

Authors:  Denise Campbell; David W Mudge; Jonathan C Craig; David W Johnson; Allison Tong; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2017-04-08

2.  The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.

Authors:  Lei Zhang; Sunil V Badve; Elaine M Pascoe; Elaine Beller; Alan Cass; Carolyn Clark; Janak de Zoysa; Nicole M Isbel; Steven McTaggart; Alicia T Morrish; E Geoffrey Playford; Anish Scaria; Paul Snelling; Liza A Vergara; Carmel M Hawley; David W Johnson
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

3.  Enhancing research publications and advancing scientific writing in health research collaborations: sharing lessons learnt from the trenches.

Authors:  Guowei Li; Yanling Jin; Lawrence Mbuagbaw; Lisa Dolovich; Jonathan D Adachi; Mitchell Ah Levine; Deborah Cook; Zainab Samaan; Lehana Thabane
Journal:  J Multidiscip Healthc       Date:  2018-05-17

4.  Trends in Adaptive Design Methods in Dialysis Clinical Trials: A Systematic Review.

Authors:  Conor Judge; Robert Murphy; Catriona Reddin; Sarah Cormican; Andrew Smyth; Martin O'Halloran; Martin J O'Donnell
Journal:  Kidney Med       Date:  2021-08-20

Review 5.  Imputation of missing covariate in randomized controlled trials with a continuous outcome: Scoping review and new results.

Authors:  Mutamba T Kayembe; Shahab Jolani; Frans E S Tan; Gerard J P van Breukelen
Journal:  Pharm Stat       Date:  2020-06-08       Impact factor: 1.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.